cycloheximide has been researched along with leuprolide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Cataldo, NA; Giudice, LC; Woodruff, TK | 1 |
Kuramoto, M; Ogawa, M; Yamashita, J | 1 |
3 other study(ies) available for cycloheximide and leuprolide
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Regulation of insulin-like growth factor binding protein production by human luteinizing granulosa cells cultured in defined medium.
Topics: Autoradiography; Bucladesine; Carrier Proteins; Cell Division; Cells, Cultured; Chorionic Gonadotropin; Colforsin; Culture Techniques; Cycloheximide; Electrophoresis, Polyacrylamide Gel; Female; Granulosa Cells; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Iodine Radioisotopes; Kinetics; Leuprolide; Methionine; Radioligand Assay; Sulfur Radioisotopes | 1993 |
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured | 1995 |